Home | All results_reference

[RDF data]
Results Reference #1293

Resource URI: http://static.linkedct.org/resource/results_reference/1293
linkedct:citation Nimeiri HS, Maki RG, Kasza K, et al.: Activity of sorafenib (SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal tumors (GIST): a phase II trial of the University of Chicago Phase II Consortium. [Abstract] American Society of Clinical Oncology 2008 Gastrointestinal Cancers Symposium, 25-27 January 2008, Orlando, FL. A-7, 2008.
rdfs:label Results Reference #1293
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00265798>
linkedct:results_reference_id 1293 (xsd:int)
rdf:type linkedct:results_reference